image
Inhibrx Biosciences, Inc. INBX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 13.83
-3.49 %
$ 200 M
Market Cap
0.12
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -17.36% -66.20% -69.78%
Annual Report FY 10-K 2022-12-31 -69.43% -77.61% -68.64%
Annual Report FY 10-K 2021-12-31 -44.37% -8.11% -13.52%
Annual Report FY 10-K 2020-12-31 40.86% -47.15% -54.28%
Annual Report FY 10-K 2019-12-31 21.24% -64.94% -48.12%
Annual Report FY 10-K 2018-12-31 -5.66% -60.29% -49.60%
Annual Report FY 10-K 2017-12-31 19.24% -135.12% -62.42%
Annual Report FY 10-K 2016-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 15.30% -2.12%
Quarterly Report Q2 8-K 2024-06-30 233.33% 4048.85% -289.22%
Quarterly Report Q1 8-K 2024-03-31 0.00% -61.65% -68.68%
Quarterly Report Q4 8-K 2023-12-31 496.35% -128.78% -148.70%
Quarterly Report Q3 8-K 2023-09-30 -57.19% -27.41% -52.74%
Quarterly Report Q2 8-K 2023-06-30 -95.78% -24.70% -19.49%
Quarterly Report Q1 8-K 2023-03-31 -98.14% -45.39% -50.83%
Quarterly Report Q4 8-K 2022-12-31 -90.34% -93.10% -82.95%
Quarterly Report Q3 8-K 2022-09-30 -88.92% -97.51% -59.58%
Quarterly Report Q2 8-K 2022-06-30 -22.55% -82.19% -74.72%
Quarterly Report Q1 8-K 2022-03-31 6.03% -73.63% -56.36%
Quarterly Report Q4 8-K 2021-12-31 2.16% -20.06% -13.43%
Quarterly Report Q3 8-K 2021-09-30 -56.95% -0.40% -20.84%
Quarterly Report Q2 8-K 2021-06-30 -72.47% -15.80% -15.34%
Quarterly Report Q1 8-K 2021-03-31 -1.03% 4.00% -5.38%
Quarterly Report Q4 8-K 2020-12-31 939.70% -8.24% -3.97%
Quarterly Report Q3 8-K 2020-09-30 633.75% -1.66% -19.25%
Quarterly Report Q2 8-K 2020-06-30 233.40% -61.34% -61.94%
Quarterly Report Q1 8-K 2020-03-31 -87.60% -422.30% -387.57%
Quarterly Report Q4 8-K 2019-12-31 -89.32% -127.85% -146.58%
Quarterly Report Q3 8-K 2019-09-30 -68.24% -115.53% -46.64%
Quarterly Report Q2 8-K 2019-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2019-03-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2018-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2018-03-31 0.00% 0.00% 0.00%